07:00
Opening remarks
Don Webber (US)
Programme
Browse the programme by date and add sessions or individual talks to My Agenda.
Filter programme
Tuesday, September 22, 2026
Offsite
TTS Congress Fun Run & Walk - IMEX at Palm Grove
TTS Congress Fun Run & Walk - IMEX at Palm Grove
No lectures assigned yet.
Parkside 1&2
Bridge to Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs
Bridge to Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs
Chair
Don Webber (US)
Organized by
Presentations
07:00
07:05
HOPE in contemporary clinical practice: Workflow, latest data, and outcome trends
Anji Wall (US)
07:20
Viability assessment: Current approaches and evolving standards
Andrea Schlegel (US)
07:35
Extended applications of HOPE beyond standard use: Pediatric, living donor, surgical, multivisceral, and intestinal applications
Francisco Hernández Oliveros (ES)
07:50
Discussion and closing remarks
Don Webber (US)
Morning Abstract and Concurrent Sessions
Cockle Bay 1
Prediction of kidney transplant outcomes
Prediction of kidney transplant outcomes
Chairs
Tracey Ying (AU) · Vikas Sridhar (CA)
Presentations
Oral Presentation
08:00
A dynamic prediction model for transplant renal artery stenosis based on donor atherosclerotic lesions at the renal artery ostium
Yiling Fang (CN)
Mini-Oral Presentation
08:10
Impact of baseline isoagglutinin titer on outcomes in ABO-incompatible kidney transplantation: a French multicenter study
Lionel Couzi (FR)
08:17
Prognostic significance of early donor-derived cell-free DNA elevations after kidney transplantation
Didier Mandelbrot (US)
08:24
The impact of the type of post-transplant thrombotic microangiopathy on graft and patient outcomes
Ekaterina Ivanova (RU)
08:31
Performance of Computable Phenotypes for Identification of Immunosuppression Related Complications in Kidney Transplant Recipients within the Patient-Centered Clinical Research Network
Vikas Dharnidharka (US)
08:38
Molecular HLA matching as predictive factors for graft and patient outcomes in kidney transplantation: a systematic review
Kristy Nguyen (AU)
Rapid-Fire Presentation
08:45
The Canadian Highly Sensitized Patient (HSP) program: post–deceased donor kidney transplant survival comparable to national benchmarks
Michel Paquet (CA)
08:50
Mediation analysis of delayed graft function and graft loss in kidney transplant recipients
Dharshana Sabanayagam (AU)
08:55
Short-term PM2.5 Exposure and Hospital Readmission After Kidney Transplantation: A Nationwide Time-Stratified Case-Crossover Study
Ting Lu (US)
Cockle Bay 2
Omics in transplantation 2
Omics in transplantation 2
Presentations
Oral Presentation
08:00
Integrating radiomics and spatial transcriptomics for predicting hepatocellular carcinoma post-transplant recurrence and deciphering the metastatic-permissive spatial niche
Zhikai Jiang (CN)
08:10
Spatial single-cell mapping of liver allograft inflammation reveals distinct immune microenvironments
Timucin Taner (US)
08:20
Ccl5⁺ Macrophages Orchestrate Immunometabolic Interaction in Cardiac Allograft Rejection via Integrated Multi-Omics
Quan Zhuang (CN)
Mini-Oral Presentation
08:30
Temporospatial profiling reveals three-way T cell chimerism and alloreactivity in a patient receiving a second intestinal transplant
Jianing Fu (US)
08:37
Comparative Analysis of Outcomes and Perfusate Proteomics from a High-Volume U.S. Center
Tiffany Lim (US)
08:44
Defining the Immune-Metabolic Landscape of Aged Allografts: Insights from Metabolomic Profiling in Acute Heart Transplant Rejection
Sarah Tsou (US)
Room C3.3
Mechanisms and management of AMR in kidney transplant recipients
Mechanisms and management of AMR in kidney transplant recipients
Chairs
Tongyu Zhu (CN) · Ruth Sapir-Pichhadze (CA)
Presentations
Oral Presentation
08:00
Prolonged CD38 targeting with felzartamab achieves sustained suppression of antibody-mediated rejection in kidney transplant recipients: a biomarker-guided open-label phase 2 extension
Katharina Mayer (AT)
08:10
Unbiased and Spatial Proteomics of Kidney Allograft Biopsies: Terminal Complement Proteins Dominate Chronic Active Antibody Mediated Rejection
Maya Allen (CA)
Mini-Oral Presentation
08:20
HLA Eplet-based risk stratification for DSA and ABMR after kidney transplantation with validation of immunogenicity and immunoreactivity
Zhou Guxiang (CN)
Rapid-Fire Presentation
08:27
Novel IgG-Degrading Enzyme Therapy for the Desensitization in Highly HLA-sensitized Kidney Transplant Recipients: A Phase 2 Study
Yongbo Wang (CN)
08:32
Characteristics of non-HLA antibodies in patients after kidney transplantation and their association with renal allograft pathological status
Meihe Li (CN)
08:37
Extracorporeal photopheresis for antibody-mediated rejection in kidney transplant recipients at high risk of infection: A case series
Nikolina Basic-Jukic (HR)
Mini-Oral Presentation
08:42
Tissue effector signatures define distinct mechanistic phenotypes of microvascular inflammation and predict kidney allograft outcomes beyond DSA and C4d
Binnaz Handan Ozdemir (TR)
Room C3.4-C3.5
Immunoregulation: Tolerance versus rejection 1
Immunoregulation: Tolerance versus rejection 1
Chairs
Alexandra Sharland (AU) · Andrea Bähr (DE)
Presentations
Oral Presentation
08:00
Microplastic Exposure Accelerates Graft Loss in a Murine Chronic Cardiac Allograft Rejection Model
Quan Zhuang (CN)
08:10
Donor γδ T cells promote blood chimerism while recipient γδ T cells contribute to graft rejection after human intestinal transplantation
Bing Chen (CN)
Mini-Oral Presentation
08:20
CD300a Regulates T Cell Function to Promote Allogeneic Cardiac Graft Survival
Helong Dai (CN)
08:27
Single-cell multi-omics characterization of rejection in transplanted kidneys reveals key cell types and a regulator of chronic rejection
Bingxuan Zheng (CN)
08:34
Leucine restriction attenuates memory-like NK-cell alloreactivity associated with subset redistribution
Jifu Ge (CN)
08:41
🎗Longitudinal dd-cfDNA Dynamics Enable Early Detection of Acute Rejection in Pediatric Liver Transplant Recipients
Agostina Arrigone (AR)
08:48
Chronic lung allograft dysfunction phenotype is associated with recipient KIR genotypes
Samuel Robinson (AU)
Room C3.6
Emerging challenges in transplantation: Allocation, risk prediction, and long-term outcomes
Emerging challenges in transplantation: Allocation, risk prediction, and long-term outcomes
Chairs
Lachlan McMichael (AU) · Ross Francis (AU)
Presentations
Oral Presentation
08:00
The rate of glomerulosclerosis as a potential criterion for allocation of marginal kidneys into single or dual kidney transplantation
Jia Sheng Xie (CN)
08:10
Body-composition abnormalities and post-transplant prognosis in hepatocellular carcinoma liver transplantation: a multi-task clinical surrogate model
Jinyan Chen (CN)
08:20
Initial kidney graft function and its association with short- and long-term graft outcomes: a paired kidney analysis
Wai Lim (AU)
08:30
Development of a Machine Learning Model to Predict 90-Day Mortality Risk After Deceased-Donor Kidney Transplantation
Sergio Salcedo Herrera (CO)
08:40
Liver transplantation disparties by ABO blood type in the machine perfusion era
Elizabeth Swanson (US)
Room C4.1
Delivering value in liver transplantation: Innovation, resources, and the future of care
Delivering value in liver transplantation: Innovation, resources, and the future of care
Presentations
08:00
Implementing change and managing resources: Can we do both?
Alfred Kow (SG)
08:20
Defining value in liver transplantation: Focusing on what matters
Julie K. Heimbach (US)
08:40
Telemedicine and remote monitoring: the potential of digital health tools to optimise patient care
Brooke Huuskes (AU)
Room C4.5
Long-term outcomes and risk stratification after liver transplantation
Long-term outcomes and risk stratification after liver transplantation
Presentations
Mini-Oral Presentation
08:00
Harnessing the estrogen-PARP axis: A key to enhancing liver graft survival and combating fibrosis
Binnaz Handan Ozdemir (TR)
08:07
Early Post-Transplant Recipient-Derived Cell-Free DNA Predicts One-Year Graft Survival in Liver Transplant Recipients
Eun-Ki Min (KR)
08:14
25 years of pregnancy outcomes after liver transplantation
Lisa A. Coscia (US)
08:21
Temporal changes in graft failure over three decades of liver transplantation: Insights from ultra-long-term outcomes with well-maintained follow-up at a single center
Masaaki Hirata (JP)
Rapid-Fire Presentation
08:28
Post-transplant MASLD does not adversely affect long-term survival or cardiometabolic outcomes following liver transplantation
Ki Sang Jung (KR)
08:33
Liver Transplantation After TARE Downstaging in Advanced Hepatocellular Carcinoma: A Single-Center Experience
Dahyun Jung (KR)
08:38
A 25-year experience of a “free of cost” dedicated living donor clinic in a low-middle-income countries. An insight into impediments to compliance in regular yearly follow-up and their impact on long-term outcomes
Mirza Zafar (PK)
Room C4.6
Expanding transplant access: Innovations in training, simulation, and global collaboration
Expanding transplant access: Innovations in training, simulation, and global collaboration
Chairs
Jen Li (AU) · Marti Manyalich Vidal (ES)
Presentations
Oral Presentation
08:00
World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and Kindness
Peggy John (CA)
Co-Presenting: World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and Kindness
David Thomson (ZA)
08:13
🎗Barriers to Kidney Transplantation Among Dialysis Patients in a Low-Middle Income Country: A Large Patient-Reported Survey
Ruchir Dave (IN)
Mini-Oral Presentation
08:23
MNGIE: Largest single-center experience of a comprehensive multidisciplinary clinic and diverse therapeutic methodologies
Ehab Abufarhaneh (CA)
08:44
Strengthening organ donation systems through workforce capacity building: Implementation evaluation of the essential skills in organ donation training program
Amal AlFar (AE)
Room C4.7
Optimizing pancreas and islet transplantation: From donor selection and graft preservation to functional outcomes
Optimizing pancreas and islet transplantation: From donor selection and graft preservation to functional outcomes
Chairs
John Kanellis (AU) · Raja Kandaswamy (US)
Presentations
Oral Presentation
08:00
Membrane-anchored ROS scavenger protects pancreatic islets from hypoxic injury by preserving surface thiol homeostasis
Jianmin Wu (CN)
Mini-Oral Presentation
08:10
Post-Transplant Diabetes in SPK
Lucas Garcias (AR)
08:17
🎗Challenging the marginal label: Pediatric donors in simultaneous pancreas–kidney transplantation
Belmin B J Winston Gysley (IN)
08:24
Biophysical profiling of human pancreatic organoids identifies mass density as a size-independent metric of maturation and function
Giuseppe Pettinato (US)
08:31
🎗Temporal trends in surgical morbidity and outcomes following Simultaneous Pancreas Kidney Transplantation: A 10 year single centre experience
Sai Praneeth Reddy Perugu (IN)
Rapid-Fire Presentation
08:38
Refining donor selection to expand the pancreatic islet donor pool: a retrospective cohort study
Heyang Wen (AU)
08:43
Allogeneic islet transplantation for diabetic patient post-kidney transplant diabetes in 4 cases
Yang Li (CN)
Room C4.8
Viral infections in transplantation
Viral infections in transplantation
Chairs
Monica Slavin (AU) · Bradley Gardiner (AU)
Presentations
Oral Presentation
08:00
🎗Mapping the BK polyomavirus MHC class I immunopeptidome to advance antiviral immune target discovery in kidney transplants
Tirath Dwivedi (AU)
Mini-Oral Presentation
08:10
Unsupervised Machine Learning Reveals Early BKPyV DNAemia Trajectories That Improve the Prediction of Kidney Allograft Outcomes
Gang Huang (CN)
08:17
Breakthrough CMV DNAemia in solid organ recipients on primary valganciclovir prophylaxis
Sara Belga (CA)
08:24
Cytomegalovirus DNAemia clearance with maribavir in solid organ transplant recipients with symptomatic versus asymptomatic infection: a post hoc analysis of phase 2 and 3 trials
Deepali Kumar (CA)
08:31
When CMV donor/recipient risk is not one-size-fits-all: Demographic and socioeconomic modification of CMV-associated mortality after heart transplantation
Maheen Abidi (US)
08:38
Extended antiviral prophylaxis mitigates impact of cytomegalovirus infection in seronegative lung transplant recipients
Manushika Watagodakumbura (AU)
Rapid-Fire Presentation
08:45
Early Initiation of Letermovir Prophylaxis Prevents Cytomegalovirus Infection After Liver Transplantation: A Prospective Single-Center Study
Katsunori Sakamoto (JP)
08:50
CMV specific cell mediated immunity profile in Indian kidney transplant recipients
Ramanand Sivaprasad (IN)
08:55
Utilization, Prevention, and Outcomes of Kidney Transplantation from HBsAg(+) Donors to HBsAg(-) Recipients: A Nationwide Survey of 74 Centers in Mainland China
Ying Su (CN)
Room C4.9
Novel immunosuppression
Novel immunosuppression
Presentations
Oral Presentation
08:00
Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection
Andrew B. Adams (US)
08:13
CCL22-engineered MSCs modulate immune crosstalk to shape an immunosuppressive microenvironment for graft protection
Yanan Li (CN)
Mini-Oral Presentation
08:23
Efficacy and safety of everolimus added to Tacrolimus/Mycophenolate/Prednisone in HLA-sensitized kidney transplant recipients: A randomized controled trial.
Elias David-Neto (BR)
08:30
🎗Targeted Elimination of ABO-Specific B Cells via Bispecific T-Cell-Engaging Antibody Conjugates for ABO-Incompatible Kidney Transplantation
Joon Young Jang (KR)
08:37
🎗CCR10 Defines a Potent Regulatory T Cell Subset Essential for Kidney Transplant Tolerance through Enhanced Foxp3 Lineage Stability
Siyue Chen (CN)
Rapid-Fire Presentation
08:44
Comparative effectiveness of thymoglobulin versus basiliximab for induction immunosuppression in older kidney transplant recipients: A target trial emulation
Katharine Krupp (US)
08:49
Bioequivalence of generic immunosuppressants in kidney transplants
Anders Asberg (NO)
Room C4.10
Pediatric treatments on the Horizon
Pediatric treatments on the Horizon
Presentations
08:00
Partial heart transplant in children
Edo Bedzra (US)
08:20
The micorbiome and transplantation
Maria-Luisa Alegre (US)
08:40
Regulatory cell therapy for solid organ transplantation
Fadi Issa (GB)
Room C4.11
Bridging gaps in transplantation: Equity, access, and unmet needs worldwide
Bridging gaps in transplantation: Equity, access, and unmet needs worldwide
Presentations
Mini-Oral Presentation
08:00
🎗Estimating the scale of unmet solid organ transplantation need in India: a demographic scenario analysis to 2040
Saurabh Puri (IN)
08:07
🎗Financial sustainability of Transplant Programs in low middle-income countries. A snapshot of models providing “free of cost” transplant services
Mirza Zafar (PK)
08:14
Qualitative methodologies exploring pregnancy care for First Nations women with kidney transplantation: An Aboriginal kidney care together improving outcomes now (AKction2) co-designed study
Nishanta Tangirala (AU)
08:21
“I won’t offer a kidney that I don’t think they should accept”: Nephrologists’ perspectives on patient involvement in declined deceased donor kidney transplant offers
Alison Weightman (AU)
08:28
The economics of kidney replacement therapy in Tanzania: a generalizable, state-transition model for policy-driven cost-effectiveness analyses
Alan Zambeli-Ljepović (US)
Rapid-Fire Presentation
08:35
A Time-to-Equivalent Risk (TiTER) for decision-making in deceased donor kidney transplant candidates
Jin Hyeog Lee (KR)
08:40
Sex Disparities in Transplant Waitlisting- Differences by Race, Ethnicity, and Age
Mara McAdams DeMarco (US)
08:45
Impact of the MELD-based allocation system on waitlist mortality and transplant rates in Japan: A single-center study
Ryoichi Goto (JP)
08:50
Improving organ donation in medicolegal cases a retrospective review from the UAE national center for organ donation and transplant from 2023 to 2026
Maria Gomez (AE)
TTS President's Plenary
Darling Harbour
TTS President's Plenary
TTS President's Plenary
Chairs
John J. Fung (US) · Nadey Hakim (GB)
Supported by
Presentations
Introduction to TTS President
Nadey Hakim (GB)
Presidential address
John J. Fung (US)
Presentation of the WIT Awards
Germaine Wong (AU)
Woman Leader in Transplantation Recipient
Beatriz Domínguez-Gil (ES)
WIT Unsung Hero Recipient
Thu Du (VN)
Medawar Awards
John J. Fung (US)
Introduction to Gabriel Danovitch
Jeremy Chapman (AU)
🎗2026 Medawar Recipient
Gabriel Danovitch (US)
Introduction to Maria Siemionow
John J. Fung (US)
🎗Medawar Recipient
Maria Siemionow (US)
Introduction to Haibo Wang
John J. Fung (US)
Beyond technology: Building a collaborative societal ecosystem for transplantation (Reflections from China's transplant reform)
Haibo Wang (CN)
An outside-in perspective on China
Björn Nashan (CN)
Coffee Break / Exhibits and Poster Viewing
Hall 1-2
Coffee Break
Coffee Break
No lectures assigned yet.
TTS Connect & Converse Theatre
Interview and Q&A discussions with award recipients
Interview and Q&A discussions with award recipients
Chair
Macey L. Levan (US)
Presentations
Q&A discussion with 2026 TTS - Dr. Sanjeev Kanoria Liver Transplant Award recipient
Peter J. Friend (GB)
Q&A discussion with 2026 TTS - Dr. Sanjeev Kanoria Liver Transplant Award recipient
Maria Amalia Matamoros (CR)
2026 TTS Medawar Recipient
Gabriel Danovitch (US)
2026 TTS Medawar Recipient
Maria Siemionow (US)
Abstract and Concurrent Sessions
Cockle Bay 1
Donor risk and recipient outcomes in kidney transplantation
Donor risk and recipient outcomes in kidney transplantation
Chairs
Angela Webster (AU) · John S. Gill (CA)
Presentations
Oral Presentation
11:00
The Impact of The Modified Kidney Donor Profile Index on The Non-use of Kidneys from Donors with Hepatitis C
Tarek Alhamad (US)
Mini-Oral Presentation
11:10
Does pre-donation cardiac arrest affect post-transplant outcomes in kidney transplantation: a UK NHSBT Registry Data Analysis
Zaid Al-Amiedy (GB)
11:17
1-year outcomes of kidney transplantation from donation after circulatory death using normothermic regional perfusion (NRP) – a single-center experience
Alex Zendel (US)
11:24
Long-term outcomes of kidneys from donors following medical assistance in dying
François Méthot (CA)
Rapid-Fire Presentation
11:31
Donor factors associated with poor early graft outcomes – a retrospective observational study over two decades from the ANZDATA registry
Gina Davis (AU)
11:36
Imaging-based nephron mass estimation using BSA-normalized CT renal volume predicts early remnant kidney dysfunction in living kidney donors
Manish Malik (IN)
11:41
Eplet mismatch does not predict outcomes in living related kidney transplantation as induction therapy overrides molecular risk
Kapil Vijaykumar Gothwal (IN)
11:46
Association between donor albuminuria and the risk of graft failure in living-donor kidney transplantation: A retrospective cohort study
Chengze Liang (CN)
11:51
Quality of Life After Living-Related Kidney Donation in an Indigenous High Volume Transplant Programme in Nigeria: Determinants from a WHOQOL-BREF Analysis.
Hyginus Ekwuazi (NG)
Cockle Bay 2
Immunosuppression: Experimental and clinical
Immunosuppression: Experimental and clinical
Presentations
Oral Presentation
11:00
Pre‑IND Evaluation of Orthotopic Cardiac Xenotransplantation Using Ten‑Gene‑Edited Porcine Donor Hearts with a Clinically Relevant Immunosuppressive Regimen in Non‑Human Primates
Muhammad Mohiuddin (US)
11:12
🎗Engineering tacrolimus-resistant A2-CAR Tregs for use in solid organ transplantation
Robert Wright (CA)
11:24
Donor carbon monoxide treatment alone prolongs pulmonary allograft survival and suppresses brain death-induced graft inflammation in CLAWN miniature swine
Hisashi Sahara (JP)
11:36
Lung allograft VCAM-1: a ligand for graft targeting of nanoparticles post-lung transplantation
Logan Langerude (US)
Room C3.3
Immunologic risk, donor factors and predictive modelling of kidney transplant outcomes
Immunologic risk, donor factors and predictive modelling of kidney transplant outcomes
Chairs
Alessandra Orsillo (AU) · Kate Wyburn (AU)
Presentations
Mini-Oral Presentation
11:00
Three-year incidence and phenotype of de novo donor-specific antibodies and complement-binding subsets after kidney transplantation: results from the DOSAKOM phase IV cohort
Jun Bae Bang (KR)
11:07
Homozygosity at HLA-A, especially the A24 antigen, is an independent risk factor for higher PRA post-transplant and reduced opportunities of subsequent transplant
Gerard Chu (AU)
11:14
Impact of donor hypertension on kidney transplant outcomes - An analysis of the Collaborative Transplant Study (CTS)
Christian Unterrainer (DE)
11:21
Temporal decay in the performance of Cox proportional hazards models for deceased-donor kidney graft survival
Aniket Sinha (AU)
Rapid-Fire Presentation
11:28
Development of a multidimensional machine learning model integrating clinical, perfusion, donor scoring and pathology data for predicting delayed graft function in deceased donor kidney transplantation
Guozhen Chen (CN)
11:33
Serum induced trained immunity responses are associated with clinical outcomes after pediatric kidney transplantation
Longshan Liu (CN)
11:38
Gene Spark: Genetic Survey of Paediatric Kidney Transplant Patients
Ananya Deshpande (AU)
11:43
Longitudinal Graft Function Trajectories in Crossmatch-Positive Living Kidney Transplantation
Toshihito Hirai (JP)
11:48
Machine learning prediction of 30-day bleeding complications in desensitized kidney transplant recipients
Ahram Han (KR)
11:53
A systematic method to evaluate kidney allocation algorithms in Australia
Owen Ng (AU)
Room C3.4-C3.5
Immunoregulation: Cell signalling 1
Immunoregulation: Cell signalling 1
Chairs
Michaela Lucas (AU) · Shane Grey (AU)
Presentations
Oral Presentation
Targeting VDR-sirt5-PHB2-mediated mitophagy to reverse vascular endMT and prevent chronic renal allograft dysfunction
Qinghuan Shen (CN)
G-MDSC derived LETS1 promotes mesenchymal stem cell differentiation into myofibroblasts via targeting TGF Beta Receptor I in renal fibrosis
Xinhao Niu (CN)
A mechanistic model to investigate Non-HLA Mismatches in LIMS1-GCC2.
Madhav Menon (US)
Targeting Innate Allorecognition Via CD47-Sirpa Prolongs Cardiac Allograft Survival In Presensitized Recipients
Martin Oberbarnscheidt (US)
The transcription factor Bhlhe40 promotes alloreactive CD8+ T cell differentiation from TCF-1+ effector progenitors in Graft-vs-Host Disease
Kate Gartlan (AU)
Room C3.6
Multi-omics and immune profiling in transplantation: Kidney-focused advances with cross-organ insights
Multi-omics and immune profiling in transplantation: Kidney-focused advances with cross-organ insights
Chairs
Ruth Sapir-Pichhadze (CA) · Jen Li (AU)
Presentations
Oral Presentation
11:00
Deep Characterization of the Kidney Transplant Immune Microenvironment via Multimodal Deep Learning and Single-Cell Spatial Transcriptomics
Jiaheng Wu (CN)
11:10
Distinguishing Pathogenic Alloimmunity from Immunological Noise in DSA-Negative Kidney Rejection: A Multimodal Framework Validated in GSTT1-Null Recipients
Xiantian Pan (CN)
Mini-Oral Presentation
11:20
Spatial multi-omics dissection of tertiary lymphoid structure maturation and composition predicts post-transplant outcomes and pre-operative immunotherapy response in hepatocellular carcinoma
Zhikai Jiang (CN)
11:27
A systematic review of reported use of genetic testing in kidney transplantation
Sadia Jahan (AU)
11:34
Integration of a pre-transplant 15-protein serum proteomic signature predicts recurrence after liver transplantation for HCC: A multicenter KOTRY registry study
Suk Kyun Hong (KR)
11:41
Potential Value of Targeting the TIM-4/PS Signaling Pathway in Promoting Immune Tolerance in Kidney Transplantation
Qiang Fu (CN)
11:48
Genome-wide investigation of variants associated with kidney allograft survival
Angelita Liang (AU)
Room C4.1
Transplant outcomes, bridging strategies, and global advances in liver transplantation
Transplant outcomes, bridging strategies, and global advances in liver transplantation
Presentations
Mini-Oral Presentation
11:00
HLA-DQ molecular mismatch-derived risk score predicts acute rejection and development of de novo donor-specific antibodies in pediatric liver transplantation
Agostina Arrigone (AR)
11:07
Liver transplantation after neoadjuvant TACE in HCC: impact of cone-beam CT on bridging and downstaging strategies assessed by the Metroticket 2.0 model
Sergey Astapovich (RU)
Rapid-Fire Presentation
11:14
Outcomes of liver transplantation for metabolic dysfunction–associated steatotic liver disease in the United States
Reza Saidi (US)
11:20
Perioperative glucose alterations and liver transplantation outcomes: A Mongolian cohort study
Sergelen Orgoi (MN)
11:25
The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program from the Paired Program
Sergelen Orgoi (MN)
11:30
Establishing a protocol for liver transplantation in unresectable colorectal liver metastases: Preliminary results of an Australian clinical trial
Arsalan Bakhtiar (AU)
11:35
Optimal frequency of high-flow hemodiafiltration as a bridging therapy to liver transplantation in patients with acute liver failure in Japan.
Kosei Nakamura (JP)
11:40
Efficacy of transarterial radioembolization versus transarterial chemoembolization as bridging therapy to liver transplantation for patients with hepatocellular carcinoma
Arpit Amin (US)
11:45
Liver transplantation outcomes in patients with secondary biliary cirrhosis following bile duct injury
Eduardo Massabki (BR)
Room C4.2
Vascularized composite allotransplantation: Expanding frontiers in function, immunity, and clinical translation
Vascularized composite allotransplantation: Expanding frontiers in function, immunity, and clinical translation
Chairs
Patrik Lassus (FI) · Peter J. Friend (GB)
Presentations
Mini-Oral Presentation
11:00
Defining long-term functional recovery in face transplantation
Bruce Gelb (US)
11:07
3-year longitudinal outcomes after the world’s first human whole eye transplant
Bruce Gelb (US)
11:14
Human limb preservation using oxygenated machine perfusion with hemoglobin-based oxygen carriers modulates hypoxia and immune injury pathways
Varun Kopparthy (US)
11:21
Vascular Composite Allograft Transplantation – A Single Center Experience From India
Shruti Tapiawala (IN)
11:28
Emerging divides in attitudes towards uterus transplantation among health professionals in Australia and New Zealand
Hayley Mallinder (AU)
11:35
Psychological and emotional profiles of Australian uterine transplant potential recipients: a comparison with international trials
Finn Campion (AU)
11:42
A decade of structural inequity in U.S. vascularized composite allotransplantation - A National OPTN Registry Analysis (1998–2024)
Girish Mour (US)
11:49
NASEM-Guided CONSORT Consensus Recommendations and Standards for Face and Hand Vascularized Composite Allotransplantation: Establishing a Multicenter Clinical Trial Framework
Vijay Gorantla (US)
Room C4.4
The journey to clinical xenotransplantation
The journey to clinical xenotransplantation
Chairs
Leonardo Riella (US) · Evelyn Salvaris (AU)
Presentations
Presenting the XenoPrize
Wayne J. Hawthorne (AU)
2025 Carl-Gustav Groth Xeno Prize for the paper on "Desensitization with Proteasome Inhibition and Costimulation Blockade Modulates the Xenoreactive Humoral Response in Nonhuman Primate Xenotransplantation"
Brendan P. Lovasik (US)
11:05
Development of the gene edited pigs to get us to the clinic
Peter Cowan (AU)
11:25
Avoiding dysregulation of the complement and coagulation-anticoagulation systems?
Richard N. Pierson (US)
11:45
The road to regulatory approval for clinical transplantation
Muhammad Mohiuddin (US)
Room C4.5
Expanding living donor liver transplantation: Emerging evidence and clinical advances
Expanding living donor liver transplantation: Emerging evidence and clinical advances
Chairs
Kwang Woong Lee (KR) · Dong Jin Joo (KR)
Presentations
Oral Presentation
11:00
Liver transplantation from donation after circulatory death in the United States: Elderly donors emerge as a critical resource
Allan Massie (US)
11:10
How Can We Ensure Donor Safety with Less than 30% of Residual Volume?
Joodong Kim (KR)
Mini-Oral Presentation
11:20
Quality of Life After Robotic Living Donor Hepatectomy: A One-Year Prospective Analysis of Donor and Recipient Determinants
Dieter Broering (SA)
11:27
A comparison of total intravenous and volatile anesthesia in living donor hepatectomy: A global prospective cohort study from the International Living Donor Liver Transplant Registry
Amer Majeed (SA)
11:34
Accuracy of MRI-PDFF and FibroScan CAP for Assessing Steatosis in Living Liver Donors: A Multivariate Analysis with Weight Stability Compensation
Eunjin Lee (KR)
Rapid-Fire Presentation
11:41
Laparoscopic Donor Left vs. Right Hepatectomy: A Propensity Score-Matched Analysis of Donor Safety and Outcomes
Eunjin Lee (KR)
11:46
Urgent liver transplantation for acute-on-chronic liver failure in national data: Impact of dynamic MELD change and donor type on survival
Jongman Kim (KR)
11:51
Beyond Consent: The Family Bereavement Trajectory Following Deceased Organ Donation
Qingqing Zhou (CN)
Room C4.6
Lung transplantation outcomes and allograft dysfunction: From mechanisms to clinical prevention strategies
Lung transplantation outcomes and allograft dysfunction: From mechanisms to clinical prevention strategies
Chairs
Gregory I. Snell (AU) · Jyotika Prasad (AU)
Presentations
Oral Presentation
11:00
Clinical, histological and tissue proteomic features of decline after idiopathic acute lung allograft dysfunction
Pamela Karas (AU)
Mini-Oral Presentation
11:10
Longitudinal immunophenotyping identifies early postoperative CD8-positive PD-1-positive T cells as an independent predictor of 1-year mortality after lung transplantation
Tianyi Yang (CN)
11:17
Predicting acute kidney injury following lung transplantation: development and internal validation of perioperative prediction models
Shogo Trevena (AU)
11:24
Family Experiences and Ethical Acceptability of Lung uDCD Authorization in an Opt-In System
Jingzhi Xu (US)
Rapid-Fire Presentation
11:31
Donor Lung Microbiome and Metabolic Signatures Predict Primary Graft Dysfunction After Lung Transplantation
Guodong Wu (CN)
11:36
Randomized controlled trial comparing immediate versus extended-release tacrolimus in lung transplant recipients: the REVOLUTION trial
Juul Daamen (NL)
11:41
Excellent Long-Term Outcomes in Paediatric Lung Transplantation Within a Centralised, Co-located Adult Program
Miranda Paraskeva (AU)
11:46
Lung Allograft Injury Improves After Gastroesophageal Reflux Surgery According To Donor-derived Cell-free DNA
Cesar Escrig (CH)
Oral Presentation
11:51
EVLP Reprograms Donor Lung Transcriptomics and Attenuates Donor-Specific Immune Signatures
Irene Bello (ES)
Room C4.7
Psychosocial, communication and educational aspects of donation and transplantation
Psychosocial, communication and educational aspects of donation and transplantation
Presentations
Oral Presentation
11:00
🎗You don’t know what you don’t know: Developing video-based educational resources for prospective kidney transplant recipients
Darren Manden (NZ)
11:10
Exploring lived experiences of kidney graft loss through narrative podcasting
Anita Slominska (CA)
Mini-Oral Presentation
11:20
Barriers to effective communication about kidney graft failure: findings to guide intervention development
Anita Slominska (CA)
11:27
'Recognizing how much the kidney transplant would hold me back': A qualitative explorative study and a digital storytelling project with young adult kidney transplant recipients
Chloe Wong-Mersereau (CA)
11:34
Posttraumatic Distress Symptoms in Patients on Mechanical Circulatory Support
Christiane Kugler (DE)
Rapid-Fire Presentation
11:41
Psychological resilience and post-kidney transplant psychosocial outcomes
Kathleen Gaudio (CA)
11:46
The role of community in the well-being of living kidney donors
Kathleen Gaudio (CA)
Room C4.8
Global Transplantation: The GODT Report Analyzes Activities Around the World
Global Transplantation: The GODT Report Analyzes Activities Around the World
Presentations
11:00
Global observatory on donation and transplantation (GODT)
Beatriz Domínguez-Gil (ES)
11:15
Global donation and transplantation activities. An assessment of 2024 GODT data
Friederike Martin (DE)
11:40
Panelist
John J. Fung (US)
Panelists
Nadey Hakim (GB)
Panelist
David Thomson (ZA)
Panelist
Dimitri A. Raptis (SA)
Room C4.9
Optimizing and utilizing old organ donors
Optimizing and utilizing old organ donors
Chairs
Helen Opdam (AU) · Jeffrey Orlowski (US)
Presentations
11:00
Setting the stage: Older organs - clinical need, ethical and economic considerations
Krista Lentine (US)
11:20
Objective quality criteria of old organs
Varvara Kirchner (US)
11:40
Old organs and ex vivo treatment
Jasper Iske (DE)
Room C4.10
Pediatric liver
Pediatric liver
Chairs
Helen Evans (NZ) · Michael Stormon (AU)
Presentations
Oral Presentation
11:00
HOPE improves outcomes of ex situ split liver grafts in pediatric liver transplantation
Javier Serradilla (ES)
11:10
Incidence of cognitive dysfunction in children after liver transplantation: a systematic review and meta-analysis
Qingqing Zhou (CN)
11:20
Liver transplantation for gestational alloimmune liver disease outcomes analysis from retrospective cohort and national case series
Shreya Tamma (US)
Mini-Oral Presentation
11:30
Infant versus paediatric liver transplantation: technical and survival outcomes in a single-centre cohort study
Yang Yang Lee (SG)
11:37
The Survival Benefit of Pediatric Liver Transplantation
Ali Abbasi (US)
11:44
The impact of early mortality on the survival benefit of pediatric liver transplantation for primary liver malignancy
Ali Abbasi (US)
Rapid-Fire Presentation
11:51
Post-Transplant Lymphoproliferative Disorder in Paediatric Liver Transplantation: A National Centre Experience from New Zealand
Yae Jhee Lee (NZ)
Room C4.11
Therapeutic organ perfusion: From organ rescue to advanced clinical applications
Therapeutic organ perfusion: From organ rescue to advanced clinical applications
Chairs
Dale Gardiner (GB) · Sarah Scheuer (AU)
Presentations
Oral Presentation
11:00
First-in-Human Application of Extracorporeal Diseased Liver Perfusion Support (EDLPS) for Liver Failure
Xiaoshun He (CN)
11:10
Development of the first pediatric DCD normothermic machine perfusion program: meeting the unmet need in pediatric liver transplantation
Chun-Sing (Kevin) Huang (US)
11:20
The First 500 Kidneys Rescued Using Subnormothermic Acellular Perfusion (SNAP) at a Centralized Facility
Giselle Guerra (US)
Mini-Oral Presentation
11:30
Subnormothermic machine perfusion for small intestinal ischemia reperfusion injury suppression and functional maintenance
Satoshi Muto (JP)
11:37
Impact of Normothermic Perfusion Strategies on Early Liver Transplant Outcomes: A Comparison of On-Site versus Back-to-Base Strategies
Santosh Nagaraju (US)
Rapid-Fire Presentation
11:44
Targeting the TCF4-COL4A-CD44 axis ameliorates neutrophil-mediated inflammation during Ex Vivo liver normothermic machine perfusion
Meiting Qin (CN)
11:49
Normothermic machine perfusion in high-acuity liver transplants with increased operative complexity: a comprehensive single-center experience
Reghan Conrey (US)
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
Parkside 1&2
Astellas Corporate Lunch Symposium on Strengthening the foundation: How consistent management drives durable graft health
Astellas Corporate Lunch Symposium on Strengthening the foundation: How consistent management drives durable graft health
Chair
Teun van Gelder (NL)
Organized by
Presentations
12:15
Opening: Examining the foundation of graft protection
Teun van Gelder (NL)
12:20
Case 1: Formulation change in a stable recipient - Is stability truly preserved?
Dirk Kuypers (BE)
12:35
Data spotlight: What do real-world evidence and guidelines tell us about formulation consistency?
Dirk Kuypers (BE)
12:45
Case 2: Increased intra-patient variability - When do you intervene?
Teun van Gelder (NL)
13:00
Discussion: Practical strategies to optimize consistency in daily practice
Teun van Gelder (NL)
13:10
Closing summary: Strengthening the foundation through consistent immunosuppression
Teun van Gelder (NL)
The Gallery
Lunch and Learn Roundtable
Lunch and Learn Roundtable
Presentations
Living donor kidney transplantation & paired exchange
Jigar Shrimali (IN)
BK Guidelines
Camille N. Kotton (US)
Transplant immunology & kidney injury
Natasha Rogers (AU)
Nursing Leadership in Transplant and Donation Systems
Anne Floden (SE)
Roundtable Mentor
Peter G. Stock (US)
DCD thoracic transplant
Gregory I. Snell (AU)
"Organ Donation: From Death to Life". How to improve education about organ donation
David Thomson (ZA)
Organ preservation, rejuvenation, and perfusion techniques
Stefan Tullius (US)
AMR in kidney transplant recipients
William Mulley (AU)
What strategies can effectively prevent unethical practices in donation and transplantation?
Maria Amalia Matamoros (CR)
TTS Connect & Converse Theatre
Meet the incoming TTS Presidents
Meet the incoming TTS Presidents
Chair
Sarah Francom (US)
Presentations
Meet the incoming TTS President
Nadey Hakim (GB)
Meet the TTS President-Elect (2026-2028)
Gabriel E. Gondolesi (US)
SOTA, Thematic and Concurrent Sessions
Cockle Bay 2
Targeting immune cell metabolism to control alloimmunity
Targeting immune cell metabolism to control alloimmunity
Presentations
13:30
How T cell metabolism regulates function and survival
Carl Atkinson (US)
13:50
Treg metabolism and the impact of metabolites on their function and disease progression
Ling Lyu (CN)
14:10
Regulation of macrophage immunometabolism to drive immunity and inflammation
Yohana Toner (NL)
14:30
T cell landscapes in the context of IL-6R inhibition after hematopoietic stem cell transplantation.
Antiopi Varelias (AU)
Room C3.3
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Chairs
Animesh Singla (AU) · Peter G. Stock (US)
Presentations
13:30
Driving quality improvement through global surgical registries
Dimitri A. Raptis (SA)
13:50
Novel outcome metrics in surgery: Beyond survival to value-based excellence
Yolanda Becker (US)
14:10
Ensuring diversity in the transplant surgery workforce
Kendra Conzen (US)
14:30
Beyond steatosis: The multisystem metabolic nature of fatty liver disease and its impact on surgical outcomes
Nazia Selzner (CA)
Room C3.4-C3.5
Deceased Donation Research: Findings and Future Directions
Deceased Donation Research: Findings and Future Directions
Chair
Dominique Martin (AU)
Presentations
13:30
Donor intervention studies – ethical and practical challenges
Dale Gardiner (GB)
13:40
Deceased donor physiological management research
Gary F. Marklin (US)
13:50
Thoracic ex-situ machine perfusion research
Sarah Scheuer (AU)
14:00
Biobanks for research
Claire Gordon (AU)
14:10
Panel Discussion
Discussion Period (AU)
Room C3.6
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Chair
Edward Geissler (DE)
Presentations
13:30
Developing an engineered heart tissue patch for heart failure.
Enzo Porrello (AU)
14:00
Pluripotent stem cells: Where are we in building new lungs?
Rhiannon Werder (AU)
14:30
Stem cell derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
Shusen Wang (CN)
Room C4.1
Biology and beyond: Multiple dimensions of transplantation
Biology and beyond: Multiple dimensions of transplantation
Presentations
13:30
Addressing gender disparity in access to pediatric kidney transplantation in India
Kinnari Vala (IN)
13:50
Social and cultural conflicts in uterine transplantation
Limor Meoded Danon (IL)
14:10
Impact of sex on cardiovascular outcomes after pediatric kidney transplantation
Rizky Indrameikha Sugianto (DE)
14:30
Intersection of sex/gender, and cancer after transplantation
Brenda Maria Rosales (AU)
Room C4.2
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Chairs
Chris Thomas (AU) · Kate Wyburn (AU)
Presentations
13:30
The long-term transplant journey: What patients experience after discharge
Liz Schick (CH)
13:45
Movement when endurance is limited: Finding confidence through everyday activity
Geoff Jessup (AU)
14:00
From recovery to endurance sport: The transformative role of movement
Kate Clark (AU)
14:15
Clinical perspective: Encouraging safe physical activity after transplant
Geoffrey McCaughan (AU)
14:30
Panel discussion: Supporting all patients to move
Discussion Period (AU)
Room C4.4
Transplanting Against the Antibody Odds
Transplanting Against the Antibody Odds
Chairs
Ankit Sharma (AU) · Anne Halpin (CA)
Presentations
13:30
Overview of new HLA tools for measuring antibodies and rapid high resolution sequencing
Sandra Tafulo (PT)
13:50
Crossing DSA in lung transplant: Is necessity the mother of invention?
Kieran Halloran (CA)
14:10
Immune memory responses: Unmasking the hidden antibody potential
Gonca E. Karahan (NL)
14:30
Organ allocation strategies for HLA compatibility
Philip Andrew Clayton (AU)
Room C4.5
Emerging infectious diseases in transplant ID
Emerging infectious diseases in transplant ID
Chairs
Olivia Smibert (AU) · Tina Marinelli (AU)
Sponsored by
Presentations
13:30
Climate change and the changing epidemiology of transplant infections
Wanessa T. Clemente (BR)
13:50
On the move: Migration and the globalization of emerging pathogens
Monica Slavin (AU)
14:10
New outbreaks of old diseases: Measles and other re-emerging threats in transplantation
Cameron R. Wolfe (US)
14:30
Disease X and vaccine
Deepali Kumar (CA)
Room C4.6
Honouring voices, changing systems: Indigenous leadership in transplant equity
Honouring voices, changing systems: Indigenous leadership in transplant equity
Presentations
13:30
Indigenous peoples and organ donation and transplantation in Canada: Improving access to care
Aviva Goldberg (CA)
13:50
Ka whawhai tonu, ka haere ake: Fighting to advance transplant equity in Aotearoa New Zealand
Curtis Walker (NZ)
14:10
Wangkanthi purdita purruna naalitya - Talking kidney health for you Mob
Kelli Owen (AU)
Co-Presenting: Wangkanthi Purdita Purruna Naalitya - Talking Kidney Health for you Mob
Stephen McDonald (AU)
14:30
Panel Discussion and Q&A
Discussion Period (AU)
Room C4.7
Artificial intelligence (AI) in Transplant Education
Artificial intelligence (AI) in Transplant Education
Presentations
13:30
From concept to classroom: How to start using AI in transplant education?
Susu Zughaier (QA)
13:50
Mixed reality technology in organ transplantation
Alfred Kow (SG)
14:10
AI in Transplantation: AI capabilities, applications and responsible use
Bill Simpson-Young (AU)
14:30
Panel Discussion
Discussion Period (AU)
Panelist
Ala Ali (IQ)
Room C4.8
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Chair
Marcelo Cantarovich (CA)
Presentations
13:30
Global organ sharing & research collaborations
Axel Rahmel (DE)
13:50
Economics of transplantation
Vasanthi Ramesh (IN)
14:10
Capacity building in low-resource settings
Medhat Askar (US)
14:30
Ethical, cultural & patient-centered considerations
Jeremy Chapman (AU)
Room C4.9
Transplant Oncology: Peering Over the Horizon
Transplant Oncology: Peering Over the Horizon
Chairs
Kwang Woong Lee (KR) · Mohamed Rela (IN)
Presentations
13:30
Liver transplantation for unresectable hilar cholangiocarcinoma: Who truly benefits?
Julie K. Heimbach (US)
13:47
Neuroendocrine tumours and liver transplantation: Time to move beyond traditional boundaries?
Takashi Ito (JP)
14:04
Intrahepatic cholangiocarcinoma and liver transplantation: Pushing the limits of what’s surgically and biologically possible
Sudha Kodali (US)
14:21
Liver transplantation for hepatoblastoma: Does biology drive the decision to transplant?
Mohamed Rela (IN)
14:38
Liver transplantation for non-hepatoblastoma paediatric tumours: LT as a curative tool?
Seisuke Sakamoto (JP)
Room C4.10
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1
Room C4.11
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Chairs
Dorry Segev (US) · Marina Berenguer (ES)
Presentations
13:30
Latest evidence on GLP-1s in transplantation
Babak Orandi (US)
14:00
Managing obesity without GLP-1s: Alternative strategies
Amanda Velazquez (US)
14:30
Facilitating weight loss in individuals with frailty and sarcopenia
Astrid Ruiz-Margáin (MX)
Coffee Break / Exhibits and Poster Viewing
Hall 1-2
Coffee Break
Coffee Break
No lectures assigned yet.
TTS Connect & Converse Theatre
DEI-WIT activities and award recipients
DEI-WIT activities and award recipients
TSANZ President Session / Afternoon Abstract and Concurrent Sessions
Cockle Bay 1
TSANZ President's Prize Awards
TSANZ President's Prize Awards
Presentations
15:30
TSANZ President's prize welcome
Nicole Isbel (AU)
15:40
Validation of a novel non-invasive method based on evaluating urinary exfoliated proximal tubule kidney cell multispectral autofluorescence to differentiate between causes of kidney transplant complications
Henry H L Wu (AU)
15:55
Developing a prediction model for the time from withdrawal of cardiorespiratory support to death in controlled donation after circulatory determination of death donors
Ryan Gately (AU)
16:10
Immune invisible kidney allografts: eliminating MHC II expression with cytosine base editing to prevent antibody-mediated kidney transplant rejection
Ailish Barry (AU)
16:25
Impact of Repeat HLA Mismatches on Graft Outcomes in Kidney Transplantation in Australia
Henry Guo (AU)
16:40
🎗A single-cell imaging atlas of the peripheral immune system in kidney transplant recipients
Griffith Perkins (AU)
16:55
Fatherhood and Kidney Replacement Therapy: Analysis of linked ANZDATA Registry and perinatal data
Su Jen Chua (AU)
17:10
Peripheral T cell transcriptomic profile is altered in non-human primate kidney transplant recipients treated with ECDI-fixed donor B cell infusions
Matthew Tunbridge (AU)
17:25
Who gets a kidney transplant? International differences in kidney transplant waitlisting, transplantation and mortality in the US, UK and Australia
Lachlan McMichael (AU)
17:40
Closing remarks
Nicole Isbel (AU)
Cockle Bay 2
Organ preservation 2
Organ preservation 2
Chairs
Henry Pleass (AU) · Michael Crawford (AU)
Presentations
Oral Presentation
15:30
Metabolic reprogramming by modulation of histone lactylation improves liver graft preservation and function
Xiao Tang (CN)
15:40
🎗Towards next-generation organ preservation - molecular insights from long-term normothermic machine perfusion of human livers for up to 7 weeks
Anita Niu (AU)
15:50
Histone acetylation improves liver graft function via ADCY3-cAMP-mediated metabolic reprogramming
Zhoucheng Wang (CN)
16:00
The First Demonstration of Kidney Allo- and Autotransplantation After 72 Hours of Simple, Cryoprotectant-Free Subzero Preservation, with Pilot Extension to 96–120 Hours
Timothy Lane Pruett (US)
Mini-Oral Presentation
16:10
Hypothermic Oxygenated or Normothermic Kidney Perfusion – Which Perfusion Technique Protects Mitochondria Best?
Keyue Sun (US)
16:17
Inhibiting ferroptosis alleviates cold-induced injury in porcine lung tissue slices
Fernanda Yamamoto Ricardo da Silva (CA)
Room C3.3
Biomarkers, pharmacokinetics and kidney allograft outcomes
Biomarkers, pharmacokinetics and kidney allograft outcomes
Chairs
Ashley Irish (AU) · John S. Gill (CA)
Presentations
Oral Presentation
15:30
Autonomous AI pathology and spatial transcriptomics reveal inflammatory niches driving i-IFTA in kidney allografts
Harry Robertson (AU)
15:40
Combined genomic transplant and pharmacogenomic risk assessment for pediatric renal patients using Oxford Nanopore Adaptive Sampling
Karen Sherwood (CA)
Mini-Oral Presentation
15:50
A Multicenter Randomized Controlled Trial Of Urine CXCL10 Monitoring Post-Kidney Transplant
Julie Ho (CA)
15:57
Consistently Low Donor-derived Cell-Free DNA Identifies Allograft Stability In Kidney Transplant Recipients
Hossein (Hoss) Tabriziani (US)
16:04
Biopsy-proven recurrent IgA nephropathy after kidney transplantation in a multi-ethnic Southeast Asian cohort
Hersharan Sran (SG)
Oral Presentation
16:11
Evaluating urinary volatile organic compounds as a novel metabolomic biomarker to differentiate between acute tubular necrosis and acute graft rejection following kidney transplantation
Henry H L Wu (AU)
Room C3.4-C3.5
Immunoregulation: Cell signalling 2
Immunoregulation: Cell signalling 2
Chairs
Kate Gartlan (AU) · Lucy Sullivan (AU)
Presentations
Oral Presentation
15:30
Investigation of immune responses to SLA-derived antigens presented on HLA class II
Ken Kawada (JP)
Mini-Oral Presentation
15:40
Spatial Transcriptome Analysis Identifies Endothelial HLA-F as a Prognostic Marker in Kidney Antibody-Mediated Rejection
Toshihito Hirai (JP)
15:47
RGS19 links autophagy dysfunction to CD8+ T cell-driven renal fibrosis via mTOR signaling
Xinhao Niu (CN)
15:54
Reversing TCMR through inhibition of innate immune allorecognition
Geoffrey Camirand (US)
16:01
The “inflamed self” – perturbations of the murine immunopeptidome during ischaemia-reperfusion injury and transplantation
Alexandra Hill (AU)
16:08
PHLDA1 as a Key Regulator in Renal Ischemia-Reperfusion Injury: Implications for Fatty Acid Metabolism and Ferroptosis
Zejiaxin Niu (CN)
16:15
Role of CXCL10 in Mediating T-Cell Infiltration and Phenotypic Remodeling in Renal Ischemia-Reperfusion Injury in Mice
Tian Wei (CN)
Room C3.6
Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care
Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care
Presentations
Oral Presentation
15:30
Edge-AI-enabled Aptamer Impedance Biosensor for Real-time Point-of-care Tacrolimus Therapeutic Drug Monitoring
Juhan Lee (KR)
15:40
A clinical study on the reduction of donor lymphocyte chimerism rate in recipient tissues after liver transplantation by extracorporeal perfusion of anti-thymocyte globulin via portal vein
Jinzhen Cai (CN)
Mini-Oral Presentation
15:50
10-year analysis of low-Tacrolimus/Everolimus versus regular triple therapy for elderly recipients. The nEVERold trial
Elias David-Neto (BR)
15:57
Proton-pump inhibitors: an opportunity for deprescribing in the solid organ transplant population
Anna Posthumus (NL)
16:04
Building model-informed precision dosing platforms for tacrolimus in lung, heart and bone marrow transplantation
Dirk Kuypers (BE)
Rapid-Fire Presentation
16:11
An algorithm-driven predictive strategy for personalized tacrolimus dosing in kidney transplant recipients
Guodong Chen (CN)
16:16
Balanced Electrolyte Solutions in Kidney Transplantation: CARI Guidelines Evidence-Based Recommendations for Improved Outcomes:
David Tunnicliffe (AU)
16:21
Efficacy and safety of low dose trimethoprim-sulfamethoxazole for pneumocystis jirovecii pneumonia in kidney transplant recipients: a retrospective cohort study
Xuqin Jiang (CN)
Room C4.1
Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility
Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility
Chairs
Richard N. Pierson (US) · Peter Cowan (AU)
Presentations
Oral Presentation
15:30
Loss of Neu5Gc in donor erythrocytes unlocks species-specific innate checkpoints governing macrophage recognition in xenotransplantation
Wang Yi (CN)
15:40
Normothermic Machine Perfusion of Human Kidneys Using Triple-Knockout Pig Red Blood Cells
Shuangjin Yu (CN)
15:50
First Large-Cohort Study Profiling the Baseline Immunological Status for Xenotransplantation in Liver Transplant Candidates: Implications for Safe Bridging from Gene-Edited Pigs
Liaoran Wang (CN)
16:00
Antibody responses against swine leukocyte antigens contribute to early rejection after pig-to-monkey kidney xenotransplantation
Hao Feng (CN)
16:10
Preformed and De Novo Xenoreactive IgM Antibodies Contribute to Early Xenograft Loss in Pig-to-Monkey Kidney Xenotransplantation
Man Zhang (CN)
Mini-Oral Presentation
16:20
Sequential Allotransplantation After Failure of Pig-to-Rhesus monkey Kidney Xenotransplantation: A Case Report
Man Zhang (CN)
16:27
Flow cytometry immune profiling provides early detection of rejection of islet xenotransplants
Thanh Le (AU)
16:34
HLA E CD94 NKG2A pathway confers superior NK cell resistance compared to extensive multitransgenic modifications in porcine endothelial cells
Jonathan Schulz (DE)
16:41
Endothelial PlexinB2 suppresses human neutrophil activation in a humanized xenotransplantation model
Shuji Miyagawa (JP)
Room C4.4
Imaging and biomarkers to assess kidney allograft dysfunction
Imaging and biomarkers to assess kidney allograft dysfunction
Chairs
Samuel Neeling (AU) · Terence Kee (SG)
Presentations
Oral Presentation
15:30
Integrated immune profiling distinguishes polyomavirus nephropathy from rejection phenotypes in kidney allografts
Binnaz Handan Ozdemir (TR)
Mini-Oral Presentation
15:40
Donor-derived Cell-free DNA As A Prognostic Biomarker In Biopsy-negative Kidney-transplant Recipients
Hossein (Hoss) Tabriziani (US)
15:47
Ultrasound assessment of the effect of patient position and body shape on peri-operative renal transplant cortical resistive indices and perfusion
Charles Fisher (AU)
15:54
Real world experience of using the molecular microscope diagnostic system MMDx in the management of allograft dysfunction in a multiethnic asian kidney transplant recipient population
Terence Kee (SG)
Rapid-Fire Presentation
16:01
The influence of ultrasound guidance quality on kidney transplant biopsy outcomes: A systematic review and meta-analysis
David Su (AU)
16:06
Genetic association in patients with chronic kidney disease of undetermined etiology: An observational study
Tarun Kumar (IN)
16:11
Donor-derived cell-free DNA during delayed graft function: Insights from the KOAR registry
Giselle Guerra (US)
16:16
Contrast-Enhanced Ultrasound in differentiating Acute Rejection from Acute Tubular Necrosis based on biopsy results in Renal Allograft Dysfunction: a Prospective Study
Sai Aishwarya Valluri (IN)
Room C4.5
Optimization strategies in living donor liver transplantation
Optimization strategies in living donor liver transplantation
Presentations
Mini-Oral Presentation
15:30
The 2023-2025 Global Report Of The International Living Donor Liver Transplant Registry
Dimitri A. Raptis (SA)
15:37
Graft-to-Recipient Weight Ratio, Graft Inflow Modulation, and Small-for-Size Syndrome: A Multicenter Prospective Study from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
Dimitri A. Raptis (SA)
15:44
Risk-Benefit Benchmarking in Liver Transplantation for Hepatocellular Carcinoma: a cohort study based on the CLTR and UNOS database
Fengqiang Gao (CN)
15:51
Impact of Preoperative Weight Reduction on Donor and Recipient Outcomes in Living Liver Transplantation
Jaehyun Kwon (KR)
15:58
Outcomes of highly urgent ABO-incompatible living donor liver transplantation in national databases
Jongman Kim (KR)
Rapid-Fire Presentation
16:05
Robotic donor hepatectomy is associated with superior long-term outcomes compared to laparoscopic or open: A single-center prospective registry study of 2,102 cases
Saleh Alabbad (SA)
16:10
Infrared Thermal Imaging Enables Real-Time Mapping of Perfusion Heterogeneity and Predicts Functional Recovery in Liver Grafts During Machine Perfusion: A First-in-Field Ex Vivo Study
Priyanka Prem (IN)
16:15
Longitudinal body composition changes following pre-donation defatting programs in living liver donors: a CT-based analysis
Francesca Albanesi (IT)
Room C4.6
Engineering immune compatibility in transplantation: Gene editing, cell therapy, and regenerative strategies
Engineering immune compatibility in transplantation: Gene editing, cell therapy, and regenerative strategies
Presentations
Oral Presentation
Construction and properties characterization of a novel ceramic membrane-based artificial kidney hemofilter
Luoyi Chen (CN)
Immortalized Hypoimmune Human Mesenchymal Stem Cells for Immunomodulation and Wound Healing
Katrin Hacke (US)
Preventive Effect of Human-Induced Renal Progenitor Cells on Delayed Graft Function After Kidney Transplantation in Rats
Haiwei Chen (CN)
Room C4.7
Solving immune problems for the life of the allograft
Solving immune problems for the life of the allograft
Chairs
Xunrong Luo (CN) · Kieran Halloran (CA)
Presentations
15:30
Single cell transcriptomic profiling focusing on donor reactive T cells of operational tolerance recipient after liver transplantation
Naoki Tanimine (JP)
15:40
🎗10-year outcomes for autologous polyclonal ex-vivo-expanded Treg cellular therapy in renal transplantation (ONE study UK Treg Trial)
Charlotte Yates (GB)
15:50
Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyond
Mariam Alexander (US)
16:10
Direct and indirect allorecognition – more alike than we thought?
Gavin Pettigrew (GB)
Room C4.8
Precision virology in transplantation: Immunity, diagnostics, and targeted therapies
Precision virology in transplantation: Immunity, diagnostics, and targeted therapies
Chairs
Matthew Roberts (AU) · Tina Marinelli (AU)
Presentations
Oral Presentation
15:30
The post-transplant lymphoproliferative disorders metagenomic shotgun microbial sequencing (PTLD-MSMS) study: clinical insights from the full cohort
Vikas Dharnidharka (US)
15:40
Phase I Clinical Evaluation of Allogeneic Virus-Specific T Cell Therapy in Solid Organ Transplant Recipients with Refractory Viral Infections
Rajiv Khanna (AU)
15:50
Measles immunity before and after solid organ transplantation: evidence for preserved protective neutralizing antibody
Camille N. Kotton (US)
Mini-Oral Presentation
16:00
Proximal Tubule-Derived SPP1 Activates Proteotoxic Stress Response and CD8⁺ T Cell Exhaustion in BK Polyomavirus Nephropathy
Yingzhen He (CN)
16:07
Virologic clearance with maribavir by baseline cytomegalovirus DNAemia in solid organ transplant recipients: A post hoc analysis of phase 2 and 3 trials
Deepali Kumar (CA)
16:14
Comparing the post-omicron transplant impact of SARS-COV2 and other respiratory viral infections
Beatrice Sim (AU)
Rapid-Fire Presentation
16:21
Real-world effectiveness and safety of maribavir in solid organ transplant recipients with refractory/resistant cytomegalovirus or intolerance to anti-cytomegalovirus drugs: Interim results from the ARISE study
Nassim Kamar (FR)
16:26
Real-world CMV hyperimmunoglobulin prophylaxis in heart and lung transplantation: one-year interim results from a prospective multicenter study
Markus Barten (DE)
16:31
Real world efficacy of maribavir when used as pre-emptive therapy for cytomegalovirus reactivation in alloHCT patients who are intolerant, refractory or resistant
Violet Zhu (AU)
16:36
Donor-Derived Severe Dengue in a Kidney Transplant Recipient Uncovered Pathogenic Neutrophil Inflammation and Protective CD14+ Monocyte Antiviral Programs
Ying Su (CN)
Room C4.9
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
Chairs
Curie Ahn (KR) · Lisa A. Coscia (US)
in collaboration with:
Presentations
15:30
Assessing risk and overcoming barriers in pregnancy after kidney transplantation
Shilpanjali Jesudason (AU)
15:50
Pregnancy after kidney transplantation: Beyond clinical outcomes—understanding barriers and experiences of first nations women
Nishanta Tangirala (AU)
Co-presenting on Pregnancy after kidney transplantation: Beyond clinical outcomes—understanding barriers and experiences of first nations women
Kelli Owen (AU)
16:10
Supporting pregnancy in transplant recipients: current best practice care and controversies
Sumoyee Basu (GB)
Room C4.11
Integrated machine perfusion strategies for DCD organ optimization and transplant outcomes
Integrated machine perfusion strategies for DCD organ optimization and transplant outcomes
Chairs
John Whitlam (AU) · Irene Bello (ES)
Presentations
Oral Presentation
15:30
Sequential NRP and hypothermic versus normothermic ex-situ perfusion in extended criteria DCD liver transplantation
Daniele Pezzati (IT)
Mini-Oral Presentation
15:40
A pragmatic alternative to commercial perfusion devices: routine liver machine perfusion using a heart–lung machine
Mikhail Boldyrev (RU)
15:47
Early outcomes after sequential hypothermic, controlled oxygenated rewarming and normothermic machine perfusion combined with TPA thrombolysis for DCD liver graft optimisation
Adam Philipoff (AU)
Rapid-Fire Presentation
15:54
🎗Automated and continuous hypothermic to normothermic machine perfusion minimises injury in porcine livers and restores function in high-risk human livers
Hatem Sadik (GB)
16:00
Routine use of the modified HTK-based perfusate for hypothermic oxygenated perfusion enables safe transplantation of suboptimal liver allografts: a single center experience
Stepan Zubenko (RU)
16:05
Impact of Hypothermic Oxygenated Machine Perfusion on Early Outcomes in Kidney Transplantation from Uncontrolled Donors
Elmira Tenchurina (RU)
16:10
Factors Associated with Prolonged Case Time in Deceased Organ Donation
Carolyn Sidoti (US)
16:15
Combined liver-kidney normothermic machine perfusion with bioartificial liver support for 48-hour ex vivo recovery of donation after circulatory death organs
Qianchao Hu (CN)
16:20
Liver and combined liver-pancreas grafts from pediatric DCD donors utilizing normothermic regional perfusion – age or size should not limit the practice
David Walls (US)
Room C4.10
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2
Workshop Sessions / Industry Symposium / Poster Sessions
Room C4.6
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Presentations
16:45
The challenge of siloed program building vs. opportunities of integration
Markus Selzner (CA)
17:09
One pathogen, two populations
Monica Slavin (AU)
17:21
Beyond the graft
Teun van Gelder (NL)
17:33
Panel discussion on global perspectives on integration and innovation
Discussion Period (AU)
Room C4.7
Approaching and navigating difficult conversations with transplant patients
Approaching and navigating difficult conversations with transplant patients
Chairs
David Thomson (ZA) · Lisa Keller (AU)
Presentations
16:45
Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplant
Rhiannon Reed (US)
17:02
Palliative care post-transplant: Throughout patient journey and symptom management
Kathryn Ducharlet (AU)
17:19
Navigating through organ failure to transplant: Liver transplant
Suk Kyun Hong (KR)
17:36
Navigating conversations on cardiac mechanical support therapy to heart transplant
Shunichi Nakagawa (US)
Hall 1-2
Poster Session 2
Poster Session 2
Industry Symposium
Room C3.3
Corporate Symposium on State-of-the-Art care for kidney transplant recipients: Implications for the forthcoming KDIGO guideline update
Corporate Symposium on State-of-the-Art care for kidney transplant recipients: Implications for the forthcoming KDIGO guideline update
This program is supported by an independent educational grant from Veloxis Pharmaceuticals, Inc.
Presentations
17:00
Opening Remarks
Germaine Wong (AU)
17:05
KDIGO's plans to update the KTR GL: What has changed and what new topics to consider
Michelle Josephson (US)
17:20
Therapeutic needs assessment in KTRs: Findings from an AST Survey
John S. Gill (CA)
17:35
What's new and exciting in kidney transplantation research: Implications for guidelines, clinicians, and transplant recipients
Germaine Wong (AU)
17:50
Closing Remarks
Germaine Wong (AU)
Networking Events
Cockle Bay 1
TSANZ Networking Event
TSANZ Networking Event
Room C4.4
International Mentee-Mentor Awards Networking Event
International Mentee-Mentor Awards Networking Event
No lectures assigned yet.
ICC Grand Ballroom
Congress Networking Event “Global Connections: Celebrating 60 years”
Congress Networking Event “Global Connections: Celebrating 60 years”
No lectures assigned yet.